UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010059
Receipt number R000011775
Scientific Title Estimating the efficacy of the oral alkalizers in patients with chronic kidney disease.
Date of disclosure of the study information 2013/02/26
Last modified on 2013/02/19 15:03:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Estimating the efficacy of the oral alkalizers in patients with chronic kidney disease.

Acronym

Efficacy of the alkalizers on CKD.
(CKOALA study)

Scientific Title

Estimating the efficacy of the oral alkalizers in patients with chronic kidney disease.

Scientific Title:Acronym

Efficacy of the alkalizers on CKD.
(CKOALA study)

Region

Japan


Condition

Condition

Chronic kidney disease.

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To estimate the efficacy of oral alkalizers in patients with CKD.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Serum creatinine level, eGFR, protein urea.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

The oral alkalizer (1) is administered for six months.

Interventions/Control_2

The oral alkalizer (2) is administered for six months.

Interventions/Control_3

The standard treatment is done for six months.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

81 years-old >

Gender

Male and Female

Key inclusion criteria

1) A patient with chronic kidney disease and age >= 20. < 81 years.
2) Signed and dated informed consent document indicating that patient has been informed of all pertinent aspects of this trial prior to enrollment.

Key exclusion criteria

1) Serious heart disease or liver disease.
2) Patients with alkaline urine.
3) Patients who are judged unfit to enroll in this trial by the investigator.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Sadayoshi Ito

Organization

Tohoku University Hospital

Division name

Division of Nephrology, Endocrinology and Vascular Medicine.

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574

TEL

022-717-7161

Email



Public contact

Name of contact person

1st name
Middle name
Last name Michiaki Abe

Organization

Tohoku University Hospital

Division name

Division of Nephrology, Endocrinology and Vascular Medicine.

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574

TEL

022-273-6289

Homepage URL


Email

michiabe@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学病院(宮城県)


Other administrative information

Date of disclosure of the study information

2013 Year 02 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2012 Year 11 Month 27 Day

Date of IRB


Anticipated trial start date

2013 Year 03 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 02 Month 17 Day

Last modified on

2013 Year 02 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011775


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name